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SUMMARY
Laboratory data are the cornerstone in surveillance of infectious disease. We investigated whether
changes in reported incidence of Campylobacter and Salmonella infection might be explained by
changes in stool sampling rates. Data were extracted from a national database on 585843 patient
stool samples tested by microbiology laboratories in Wales between 1998 and 2008. Salmonella
incidence fell from 43 to 19 episodes/100 000 population but Campylobacter incidence after
declining from 111/100 000 in 1998 to 84/100 000 in 2003 rose to 119/100 000 in 2008. The
proportion of the population sampled rose from 2.0% in 1998 to 2.8% in 2008, mostly due to
increases in samples from hospital patients and older adults. The proportion of positive samples
declined for both Salmonella and Campylobacter from 3.1% to 1.1% and from 8.9% to 7.5%,
respectively. The decline in Salmonella incidence is so substantial that it is not masked even by
increased stool sampling, but the recent rise in Campylobacter incidence may be a surveillance
artefact largely due to the increase in stool sampling in older people.
Key words : Campylobacter infections, incidence, faeces, population surveillance,
Salmonella infections.
INTRODUCTION
There are up to 17 million episodes of infectious in-
testinal disease (IID) in the UK every year [1], of
which around 1 in 4 are estimated to be caused by
indigenous foodborne infection [2]. The epidemiology
of the two most important bacterial causes,
Salmonella and Campylobacter infection, has changed
considerably in the UK over the past two decades.
Salmonella incidence has fallen sharply from a peak of
around 35000 infections in 1997, largely due to an
80% decline in Salmonella Enteritidis phage-type 4
infections between 1997 and 2008 [2]. Campylobacter
incidence reached a peak of around 60 000 infections
in 2000 and thereafter declined, but has been rising
again since 2004 particularly in older people [3].
Similar trends have been observed elsewhere in
Europe [4, 5] and the USA [6]. It is not known to
what extent these changes are real or a consequence
of surveillance artefacts.
Public health surveillance of IID and foodborne
infection usually depends on reporting of laboratory-
conﬁrmed cases, and physicians who request stool
samples are essential contributors to this process.
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However, reported infections represent only a small
fraction of cases occurring in the community. In order
to be ascertained, a patient must ﬁrst seek medical
care, a stool sample must be submitted to the labora-
tory, the laboratory must identify an organism, and
the test result must be reported to national surveil-
lance. Several epidemiological studies in the UK
[1], The Netherlands [7], the USA [8], Canada [9],
Australia [10], and New Zealand [11] have in-
vestigated the relationship between components of
this surveillance pyramid in order to provide better
estimates of the true burden of IID. For example, in
the UK in 2008–2009, for every case of Salmonella or
Campylobacter infection reported to national surveil-
lance there are estimated to be 4.7 and 9.3 cases, re-
spectively, in the community [1].
Disparities in surveillance systems, such as diﬀer-
ences in health-seeking behaviour or stool sampling
practices, may account for some of the variation in the
incidence of disease that is observed between regions
or countries. Similarly, secular disease trends might
also be aﬀected by variation in surveillance parameters
over time rather than by true change in disease inci-
dence. We analysed data from a microbiology labora-
tory network to investigate whether changes in the
epidemiology of Campylobacter or Salmonella infec-
tion over the past decade might be explained by chan-
ges in stool sampling rates.
METHODS
Laboratory surveillance system
Surveillance for Campylobacter and Salmonella in-
fections in Wales is based on laboratory reports of
culture-conﬁrmed cases. The Wales laboratory sur-
veillance network comprises all 13 microbiology lab-
oratories that are located in Wales (population 3
million) providing complete population coverage.
They perform stool sample tests for general practices,
hospitals, and a variety of other users such as occu-
pational health and environmental health depart-
ments. Laboratories follow a common standard
operating procedure and test all stool specimens for
Campylobacter spp., Salmonella spp., Shigella spp.,
Escherichia coli O157, and Cryptosporidium spp. [12].
Every sample is given a unique patient identiﬁcation
number and a unique specimen identiﬁcation number
by the laboratory. Multiple samples obtained from
the same patient can be linked by means of the
patient identiﬁcation number. Data accompanying
the sample include age, sex, place of residence, date of
sampling, source of specimen, date of test result, and
details of test result (including species and serotype, if
determined).
All microbiology laboratories in Wales participate
in a national database (DataStore) which is co-
ordinated by Public Health Wales. This includes re-
cords on all specimens processed by each laboratory
from around 1996 onwards. DataStore electronically
extracts data directly from each laboratory infor-
mation management system and compiles the data
into one large dataset with a common range of data
codes. Data were obtained fromDataStore on all stool
samples submitted in the period 1998–2008 and on all
stool samples testing positive for Campylobacter or
Salmonella infection.
DATA ANALYSIS
For our analyses we used only data from laboratories
which could deliver complete data for the full period
and where there had been no change in the laboratory
information management system that might inﬂuence
data quality. Data were checked for duplicates and
any records relating to laboratory quality control
samples were removed.
A sample was considered positive if culture con-
ﬁrmed the presence of either Campylobacter or
Salmonella infection. A patient episode was deﬁned as
a single positive sample test result. If two or more
positive results occurred within a 90-day period, the
date of the ﬁrst positive test was assigned to the epi-
sode and all other positive results within the period
were omitted. The sample yield (proportion positive)
was deﬁned as the number of patient episodes per 100
stool samples tested.
We used Stata version 10 (StataCorp, USA) to
analyse time trends (using univariate linear regression
of the number of samples or episodes over time) and
to calculate risk ratios (RR). Since samples submitted
from general practice most closely reﬂect rates of
disease in the community, we analysed data separately
by sample source (general practice, hospital, other).
Data were also stratiﬁed according to sex and age
group (0–4, 5–14, 15–44, 45–64, o65 years). Popu-
lation denominator data for Wales for the census
year 2001 were obtained from the Oﬃce for National
Statistics [13], and we used this as the reference
year to calculate annual incidence rates per 100 000
population, with 95% conﬁdence intervals (CI) as
required.
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RESULTS
Data were available on 585 843 stool samples tested
between 1998 and 2008 from nine laboratories, rep-
resenting 80% of the catchment population for
Wales. Four laboratories with incomplete data were
excluded: two small laboratories that had only re-
cently been incorporated into the national database
and two laboratories that had previously had a policy
of deleting all negative test results because of lack of
storage space on their laboratory management sys-
tem. Details of age, sex, and sample source were
available for 96.6%, 98.4% and 86.9% of patient
samples, respectively.
Campylobacter and Salmonella incidence and trends
Between 1998 and 2008, there were 26 281 episodes
of Campylobacter infection, a mean annual rate of
103/100 000 population (95% CI 95–111) and 5767
episodes of Salmonella infection, a mean annual rate
of 23/100 000 population (95% CI 18–27) (Table 1).
For Campylobacter, there was a slight excess in
the number of episodes in males (53% males, 47%
females) and a higher incidence (males 88/100 000,
females 74/100 000, RR 1.19, 95% CI 1.16–1.22,
P<0.001). For Salmonella there was a slight excess in
the number of episodes in males (51% male, 49%
female) but a similar incidence (males 17.9/100 000,
females 17.4/100 000, RR 1.03, 95% CI 0.98–1.09,
P=0.3). Both Campylobacter (120/100 000) and Sal-
monella (40/100 000) incidence was highest in the
0–4 years age group. Salmonella incidence declined
from 43/100 000 to 19/100 000 population between
1998 and 2008 but Campylobacter incidence, after
declining from 111/100 000 in 1998 to 84/100 000 in
2003, rose to 119/100 000 in 2008. Salmonella inci-
dence declined in all age groups over the study period.
However, Campylobacter incidence, after an initial
decline, increased steadily between 2003 and 2008,
especially in the 45–64 years (81–122/100 000) and
o65 years (55–96/100 000) age groups.
Stool sampling trends
Around 1 in 44 of the population submitted a stool
sample each year, a mean annual stool sampling rate
of 2256/100 000 (95% CI 2068–2445). The proportion
of the population submitting a stool sample increased
by 40% from 2.0% in 1998 (47 144 samples, 2027/
100 000 population) to 2.8% in 2008 (66 140 samples,T
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2843/100 000 population) (Table 1). Most samples
were submitted by general practices (48%) compared
to 44% from hospitals and 8% from other sources.
However, the proportion of samples from hospital
patients increased from 41% to 45% over the study
period (Fig. 1). Sampling rates were higher for fe-
males (males 43%, females 57%) and varied con-
siderably by age group, with highest mean annual
sampling rates in the 0–4 years (6654/100 000) and
o65 years (5145/100 000) age groups, Over the study
period, the male :female sampling ratio (1:1.2) re-
mained the same as did sampling rates in children
and young adults. However, sampling rates rose in
older adults (o65 years) from 3592 to 7203/100 000,
particularly from 2004 onwards (Fig. 2). This rise was
seen in samples originating from both general practice
and hospital sources.
Stool sampling patterns and yield
The yield (proportion positive) varied by source of
specimen from 9.5% in general practice samples to
1.5% in hospital samples. Campylobacter was de-
tected in 7.9% of general practice samples and 1.1%
of hospital samples, while Salmonella was detected in
1.6% and 0.4%, respectively. In general practice
samples, yield was higher in males than females for
both Salmonella (1.7% vs. 1.5%) and Campylobacter
(9.4% vs. 6.8%). Overall, the proportion positive for
Salmonella declined throughout the study period with
35 000
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Fig. 1. Number of faecal samples submitted to microbiology laboratories in Wales by sample source and year, 1998–2008.
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Fig. 2. Number of faecal samples submitted to microbiology laboratories in Wales by age group and year, 1998–2008.
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the steepest decline occurring between 1998 and 2001
while the proportion positive for Campylobacter de-
clined from 1998 to 2005 but has risen slightly since.
In general practice samples, the proportion positive
for Salmonella declined from 3.1% to 1.1% (from
3.4% to 1.2% in males and from 2.8% to 1.0% in
females), and the proportion positive for Campylo-
bacter declined from 8.9% to 7.5% (from 10.6% to
9.1% in males and from 7.6% to 6.2% in females)
(Table 2). Salmonella yield declined in all age groups
(by between 58.4% and 80.1% according to age
group) and Campylobacter yield declined by between
13.2% and 14.8% in every age group, apart from the
o65 years age group where it only declined by 7.5%.
Thus, while the annual number of general practice
samples increased on average by 2.7% per year
throughout the study period, the number of Salmon-
ella episodes declined by 7.8% per year, while the
number of Campylobacter episodes increased only
very slightly by 0.6% each year (Fig. 3).
DISCUSSION
Stool sampling rates have risen steadily since 1998,
particularly samples from hospital patients and from
people aged o65 years. In spite of this, Salmonella
incidence has continued to decline. By contrast,
Campylobacter incidence after declining between 1998
and 2003 has risen since 2004, particularly in older
people, although the proportion of samples positive
has remained almost constant. Most of this increase
may therefore be explained by higher sampling rates
in older people.
Our study captured data on stool samples submit-
ted for testing in all laboratories in Wales. It does not
take account of cross-boundary ﬂows, although we
know (from other data sources) that the proportion of
Welsh residents tested outside Wales is small. Data
from four laboratories were incomplete and were
discarded, but examination of the available data did
not show any diﬀerences from the nine laboratories
included in the study. Laboratory testing practices
may vary between laboratories or change over time,
for example the choice of culture media used, dur-
ation of incubation of culture plates, and how plates
are read [14, 15]. These can inﬂuence test sensitivity,
particularly for a fastidious organism like Campylo-
bacter. However, all laboratories in Wales follow a
standard operating procedure for investigation of
stool samples for bacterial pathogens [12] and there
was no change in testing procedures throughout the
study period. The main limitation of our study is that
only a minimum of variables are routinely captured
by laboratories on stool samples. Therefore we were
unable to investigate whether changes in stool sam-
pling rates were due to factors associated with seeking
medical care or reasons for submitting a stool sample.
Other studies have examined factors associated with
consulting a general practitioner (GP) and with having
a stool sample taken. In England, during the mid-
1990s, around 1 in 6 patients presented to a GP fol-
lowing an episode of IID and around 1 in 4 of these
had a sample taken [16]. The decision to consult a
doctor is inﬂuenced by age, illness severity, recent
travel abroad, pre-existing poor health, educational
attainment and socioeconomic status [17, 18]. Similar
Table 2. Proportion of stool samples positive for Campylobacter and Salmonella by age group and by year, general
practitioner samples, Wales, 1998–2008
Year
Campylobacter* Salmonella*
0–4 yr 5–14 yr 15–44 yr 45–64 yr o65 yr All ages 0–4 yr 5–14 yr 15–44 yr 45–64 yr o65 yr All ages
1998 4.0 7.9 12.8 12.0 5.3 8.9 2.4 5.5 3.7 3.3 1.4 3.1
1999 4.3 7.7 12.0 10.8 5.0 8.5 1.3 3.2 2.8 2.7 0.8 2.1
2000 3.8 8.2 12.3 11.5 5.1 8.7 1.0 2.5 2.3 1.9 0.8 1.7
2001 2.9 7.4 11.8 11.6 5.9 8.4 0.8 3.3 2.3 1.9 0.7 1.7
2002 2.5 6.7 10.4 10.2 5.2 7.6 1.0 3.4 1.8 1.7 0.6 1.5
2003 2.1 5.9 10.2 10.4 4.9 7.4 1.0 2.4 2.3 2.3 0.8 1.8
2004 2.6 6.1 11.0 9.6 5.0 7.5 0.8 2.6 2.1 1.9 0.6 1.5
2005 3.1 5.4 9.9 9.5 4.3 7.0 0.8 2.7 1.4 1.2 0.6 1.2
2006 2.8 6.3 11.1 10.7 5.2 7.8 0.6 1.7 1.5 1.2 0.3 1.0
2007 3.2 8.2 10.6 11.3 5.4 7.9 0.7 1.8 1.6 1.3 0.5 1.1
2008 3.4 6.7 10.9 10.3 4.9 7.5 0.7 2.3 1.6 1.3 0.3 1.1
* Proportion positive/100 sample.
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factors inﬂuence the decision by aGP to request a stool
sample for culture particularly diarrhoea duration,
bloody diarrhoea, and recent travel abroad [8, 19, 20].
There are also well-documented diﬀerences between
countries in rates for seeking medical care which are
higher in the USA, Canada, and Australia compared
to the UK and The Netherlands [8]. One recent study
investigated the almost tenfold diﬀerence in Campylo-
bacter infection rates in Australia compared to the
USA and found that these could not be explained by
diﬀerences in healthcare systems [21]. Nevertheless,
these diﬀerences in surveillance parameters potentially
aﬀect between-country comparisons of the incidence
and burden of foodborne disease.
Relatively few studies have documented stool sam-
pling rates or used laboratory denominators when
quantifying incidence rates of gastrointestinal patho-
gens. In a study in four laboratories in England from
1983 to 1984 the stool sampling rate was around 1100/
100 000 population and the yield (proportion positive)
for Campylobacter and Salmonella was 5.5% and
3.4%, respectively [22]. More recently, a study from a
single English laboratory reported a sampling rate
ranging from 1700/100 000 in 1991 to 2300/100 000 in
2000 with a yield of 5.7% for Campylobacter between
2000 and 2004 [23]. This suggests that stool sampling
rates may have been increasing throughout the 1990s.
Stool sampling rates may also vary in diﬀerent
countries. For example, they appear to be consider-
ably lower in The Netherlands, which had a mean
stool sampling rate of 1037/100 000 population
between 1996 and 2000 and yields of 3.5% and 2.3%
for Campylobacter and Salmonella, respectively [24].
There has been a large decline in Salmonella inci-
dence in the UK over the past decade [2], and this has
been so substantial that it cannot be masked even by
increased stool sampling rates. Until recently, there
was a similar but less marked decline in Campylo-
bacter incidence [2, 3]. However, a recent increase in
Campylobacter incidence, particularly in people aged
>60 years, has been described [3]. Interestingly, this
has occurred in spite of an almost 50% decrease in
GP consultation rates for IID between 1994–1996 and
2008–2009 [1, 15]. Our analysis of laboratory data
suggests that the apparent rise in Campylobacter in-
cidence may partly be a surveillance artefact due to
increased stool sampling in older people. This could
be due to demographic changes such as an increase in
the number of older people (the population of Wales
grew by 2% during the study period and the pro-
portion aged o65 years increased from 17.3% to
18.0%), but a more likely explanation is a selective
increase in sampling of older people, particularly in
hospital, because of concern about norovirus out-
breaks or antibiotic-associated diarrhoea. This is
borne out by reports of increases in hospital ad-
missions of older people with norovirus [25], and
changes in laboratory workload for Clostridium diﬃ-
cile infection [26]. However, our study cannot exclude
the possibility that some of the increase in Campylo-
bacter incidence is real. A recent major increase in
Campylobacter incidence in New Zealand, which has
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Fig. 3. Number of faecal samples, Campylobacter episodes and Salmonella episodes with trend lines by year, general
practitioner samples, Wales, 1998–2008.
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one of the highest rates in the world, was conﬁrmed
by comparing surveillance data with data on hospi-
talization [27]. Similar studies are required in order to
investigate Campylobacter trends in the UK.
In general, there are several alternative expla-
nations for apparent changes in disease incidence de-
tected through surveillance, for example changes in
demography, health-seeking behaviour, diagnostic
criteria, diagnostic practices, or reporting practices.
Trends in IID are most eﬃciently monitored using
surveillance data based on laboratory-conﬁrmed in-
fections. However, this assumes that surveillance
multipliers for each step of the surveillance pyramid
remain constant over time [28]. We have shown that
this is not the case, at least for stool sampling rates.
The recent introduction of new infectious disease
legislation in Wales that obliges diagnostic labora-
tories, for the ﬁrst time, to notify organisms of public
health concern may also aﬀect surveillance data in
future [29]. This illustrates the importance of de-
nominator data on surveillance parameters such as
stool sampling practices, and the need for exercising
caution when interpreting laboratory surveillance
data as a marker of disease incidence.
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